PC162007

PC162007 is an investigational pediatric drug being developed by Guangzhou Yipinhong Pharmaceutical (also known as ApicHope). It is formulated as a dry suspension for oral administration after reconstitution. The drug is part of the company's specialized pediatric research pipeline, which focuses on areas such as allergies, epilepsy, influenza, asthma, and viral infections. While specific details regarding its molecular target and primary indication have not been publicly disclosed, it is categorized within the company's research and development efforts for children aged 0-14 years. The development status is currently in the research phase, with multiple formulations of the dry suspension being explored.

Other names

PC162007 dry suspensionPC-162007 dry suspensionPC 162007 dry suspension